$70.090
-1.682 (-2.40%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PTCT Prediction & Forecast by Similar Chart Analysis
Alphio's PTCT stock price prediction model matches the current PTC Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $71.35 (+1.80%). The 1-week path is $69.13 (-1.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy PTC Therapeutics Inc Stock?
PTC Therapeutics Inc is a good buy right now due to its recent strong earnings report, which showed a Q2 GAAP EPS of $0.92, exceeding expectations by $0.71, and a revenue of $360.5 million, marking a 101.5% year-over-year increase. Additionally, the stock has a forward P/E of 39.68, indicating growth potential, while analysts have set price targets significantly above the current price of $70.09, with the highest target at $109. The main risk is the current RSI of 37.045, suggesting that the stock is oversold, but this can also present a buying opportunity.
PTCT stock price ended at $70.09 on Friday, after losing -2.40%
PTC Therapeutics Inc (PTCT) last closed at $70.09, losing -2.40%. These facts feed the 1-day and 1-week PTCT price prediction above.
Analyst Consensus
PTC Therapeutics Inc (PTCT): 2 buy, 5 hold, 1 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
PTC Therapeutics Inc (PTCT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PTCT, ranked by similarity.
Seasonality analysis for PTCT
Historically the probability of a positive August return for PTCT is 63.49%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PTCT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $101.31 | $113.41 | $133.69 | +61.80% |
| Sep 2026 | $70.79 | $74.95 | $88.55 | +6.94% |
| Oct 2026 | $58.76 | $99.49 | $121.98 | +41.95% |
| Nov 2026 | $49.18 | $71.96 | $96.09 | +2.67% |
| Dec 2026 | $110.62 | $113.41 | $146.32 | +61.80% |
In 2026, PTC Therapeutics Inc (PTCT) is projected to range from $49.18 to $146.32.
PTC Therapeutics Inc 2026 monthly forecast
In Aug 2026, PTC Therapeutics Inc is projected to average $113.41, with a low of $101.31 and high of $133.69.
In Sep 2026, PTC Therapeutics Inc is projected to average $74.95, with a low of $70.79 and high of $88.55.
In Oct 2026, PTC Therapeutics Inc is projected to average $99.49, with a low of $58.76 and high of $121.98.
In Nov 2026, PTC Therapeutics Inc is projected to average $71.96, with a low of $49.18 and high of $96.09.
In Dec 2026, PTC Therapeutics Inc is projected to average $113.41, with a low of $110.62 and high of $146.32.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.